The National Institute of Health and Clinical Excellence rejects new treatments for renal cell cancer: Cinderella's invitation is cancelled.
Eisen
Tim
T
Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK. tgqe2@medschl.cam.ac.uk
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000191:economics* / Q000627:therapeutic use; D002292:Carcinoma, Renal Cell / Q000188:drug therapy* / Q000191:economics; D003362:Cost-Benefit Analysis; D006801:Humans; D007680:Kidney Neoplasms / Q000188:drug therapy* / Q000191:economics; D013222:State Medicine / Q000191:economics / Q000639:trends; D006113:United Kingdom